14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 4.134 43 days ( -68.94 % )
Last Price $27.96 0.215 %
High/ Low $26.98 - $29.12 18.96%
Chg 7 Days 9.65 % $25.50 $27.96
Chg 30 Days 10.95 % $25.20 $27.96
Chg 12 mos 3,439.24 % $0.790 $27.96
Trend - 3 mos 127.20 % Width: 58.53 %
Trend - 12 mos 334.92 % Width: 184.43 %
Pred. range - 3 mos $55.94 - $88.68 100.05 % - 217.15 %
Pred. range - 12 mos $48.51 - $137.98 73.50 % - 393.49 %
Short MA avg 3 mos Buy Apr 19, 2024 - 9 days
Long MA avg 3 mos Buy Feb 27, 2024 - 46 days
Short/Long MA avg 3 mos Buy Feb 27, 2024 - 46 days
Short MA avg 12 mos Buy Apr 17, 2024 - 11 days
Long MA avg 12 mos Buy Nov 20, 2023 - 112 days
Short/Long MA avg 12 mos Buy Nov 20, 2023 - 112 days
Pivot Short Sell Mar 21, 2024 - 29 days
Bollinger Buy May 01, 2024 - 1 day
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About vTv Therapeutics Inc.

vTv Therapeutics. vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetrant phosphodiesterase type 4 (PDE4) inhibitor that addresses inflammatory diseases and psoriasis. It is a... VTVT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT